02374cam a2200445 i 4500001001300000003000600013005001700019008004100036040007600077042000800153043001200161050002200173074001100195086002000206110007700226245021600303246014600519264006000665264010100725300004600826336000800872337001600880338001900896490005900915500003600974500002501010500002501035504004101060650004101101650003401142650003401176650003401210650003201244650004001276650007101316655003401387776022201421776022601643810005901869ocn968332771OCoLC20181126145413.0170113s2016    dcua     b   f000 0 eng c  aGPObengerdacGPOdGPOdOCLCQdOCLCFdWLUdAZPdGPOdOCLCAdOCLCQdMvI  apcc  an-us---14aKF31.5b.A3 2016a  a1008-C0 aY 1.1/5:114-4291 aUnited States.bCongress.bSenate.bSpecial Committee on Aging,eauthor.10aSpecial report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs :bthe monopoly business model that harms patients, taxpayers, and the U.S. health system.30aSudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system 1aWashington :bU.S. Government Publishing Office,c2016. 2aWashington, DC :bFor sale by the Superintendent of Documents, U.S. Government Publishing Office  aiii, 130 pages :billustrations ;c24 cm.  btxt  bn2rdamedia  bnc2rdacarrier1 aReport / 114th Congress, 2d session, Senate ;v114-429  aShipping list no.: 2017-0119-P.  a"December 20, 2016."  aCRDP Program record.  aIncludes bibliographical references. 0aPrescription pricingzUnited States. 0aDrugsxPriceszUnited States. 0aGeneric drugszUnited States. 0aAntitrust lawzUnited States. 0aCompetitionzUnited States. 0aConsumer protectionzUnited States. 0aPharmaceutical industryxMoral and ethical aspectszUnited States. 7aLegislative materials.2lcgft08iOnline version:aUnited States. Congress. Senate. Special Committee on Aging.tSpecial report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugsw(OCoLC)96833260308iMicrofiche version:aUnited States. Congress. Senate. Special Committee on Aging.tSpecial report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugsw(OCoLC)9932556741 aUnited States.bCongress.bSenate.tReport ;v114-429.